When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Influenza infection

Last reviewed: 20 Oct 2025
Last updated: 19 Aug 2025

Summary

Definition

History and exam

Key diagnostic factors

  • winter season
  • current influenza outbreak
  • unvaccinated
  • fever with cough
Full details

Other diagnostic factors

  • sore throat
  • cervical lymphadenopathy
  • dyspnea
Full details

Risk factors

  • age ≥65 years
  • age 6-59 months
  • chronic cardiovascular or respiratory conditions
  • diabetes
  • hemoglobinopathy
  • immunocompromised status
  • chronic kidney disease (CKD)
  • pregnancy
  • caregivers and household contacts of high-risk groups
  • healthcare workers
Full details

Diagnostic tests

1st tests to order

  • clinical diagnosis
Full details

Tests to avoid

  • broad respiratory pathogen panels
  • serology
Full details

Tests to consider

  • molecular assays
  • antigen detection tests
  • viral culture
  • chest x-ray
Full details

Treatment algorithm

INITIAL

exposure to infected individual(s) in at-risk population

ACUTE

adults

children

Contributors

Authors

Kyle Eggleton, MBChB PhD FRNZCGP(Dist)

Associate Dean Rural

Department of General Practice and Primary Health Care

University of Auckland

Auckland

New Zealand

Disclosures

KE declares that he has no competing interests.

Rachel Roskvist, MBChB, FRNZCGP, MHSc

Senior Lecturer

Department of General Practice and Primary Health Care

University of Auckland

Auckland

New Zealand

Disclosures

RR declares that she has no competing interests.

Bruce Arroll, MBChB PhD FRNZCGP

Department of General Practice and Primary Health Care

University of Auckland

Auckland

New Zealand

Раскрытие информации

BA declares that he has no competing interests.

Выражение благодарностей

Dr Kyle Eggleton, Dr Rachel Roskvist, and Professor Bruce Arroll would like to gratefully acknowledge Dr Cristine Radojicic, a previous contributor to this topic.

Раскрытие информации

CR declares that she is on Advisory boards for CSL Behring and Speakers Bureau Biocryst.

Рецензенты

Michael Ison, MD

Chief

Respiratory Diseases Branch

National Institute of Allergy and Infectious Diseases

Bethesda

MD

Раскрытие информации

MI declares that he has no competing interests.

Waleed Javaid, MD, FACP, FIDSA

Associate Professor

Medical Director of Infection Control

Infectious Disease

Department of Medicine

SUNY Upstate Medical University

Syracuse

NY

Раскрытие информации

WJ declares that he has no competing interests.

Rachel L. Miller, MD, FAAAAI

Associate Professor of Clinical Medicine and Environmental Health Sciences

Columbia University College of Physicians and Surgeons

New York

NY

Раскрытие информации

RLM declares that she has no competing interests.

Mark Sands, MD, FAAAAI

Chief

SUNY Buffalo School of Medicine

Division Allergy and Immunology

Buffalo

NY

Раскрытие информации

MS declares that he has no competing interests.

An De Sutter, MD, PhD

Associate Professor

Department of General Practice and Primary Health Care

Ghent University

Ghent

Belgium

Раскрытие информации

ADS declares that she has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Список литературы

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

Основные статьи

Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the Infectious Diseases Society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019 Mar 5;68(6):e1-47.Полный текст  Аннотация

Centers for Disease Control and Prevention. Influenza (flu). Feb 2024 [internet publication].Полный текст

Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2024-25 Influenza Season. Aug 2024 [internet publication].Полный текст  Аннотация

Centers for Disease Control and Prevention. ​Child and adolescent immunization schedule by age (addendum updated July 2, 2025): recommendations for ages 18 years or younger, United States, 2025. Jul 2025 [internet publication].Полный текст

Centers for Disease Control and Prevention. Adult immunization schedule by age (addendum updated July 2, 2025): recommendations for ages 19 years or older, United States, 2025. Jul 2025 [internet publication].Полный текст

Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians. Dec 2023 [internet publication].Полный текст

Статьи, указанные как источники

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.

Использование этого контента попадает под действие нашего заявления об отказе от ответственности